059749018	059749018	CD	B-NP	O
|	|	NNP	I-NP	O
FHC	FHC	NNP	I-NP	O
|	|	VBD	B-VP	O
61377777	61377777	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
377097	377097	CD	B-NP	O
|	|	CC	I-NP	O
1/10/2001	1/10/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
chf	chf	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/10/2001	1/10/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/5/2001	10/5/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CZAPLINSKI	CZAPLINSKI	NNP	B-NP	O
,	,	,	O	O
LOGAN	LOGAN	NNP	B-NP	O
586-37-67-7	586-37-67-7	CD	I-NP	O
Ster	Ster	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
Perv	Perv	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/24/01	1/24/01	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GREANY	GREANY	NNP	B-NP	O
,	,	,	O	O
QUINTON	QUINTON	NNP	B-NP	O
NORBERT	NORBERT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/25/01	6/25/01	CD	B-NP	O
by	by	IN	B-PP	O
LLANES	LLANES	NNP	B-NP	O
,	,	,	O	O
GARLAND	GARLAND	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
79189197	79189197	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
DIGOXIN	DIGOXIN	NN	I-NP	I-protein
0.25	0.25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ATIVAN	ATIVAN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LORAZEPAM	LORAZEPAM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
or	or	CC	I-NP	O
insomnia	insomnia	NN	I-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

THIAMINE	THIAMINE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
THIAMINE	THIAMINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/25/01	6/25/01	CD	B-NP	O
by	by	IN	B-PP	O
PECCIA	PECCIA	NNP	B-NP	O
,	,	,	O	O
IAN	IAN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
INSULIN	INSULIN	NNP	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
fsg	fsg	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
LGRH	LGRH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
ALLEGRA	ALLEGRA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FEXOFENADINE	FEXOFENADINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
250	250	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/3	11/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
If	If	IN	B-ADJP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/25/01	6/25/01	CD	B-NP	O
by	by	IN	B-PP	O
KAZEE	KAZEE	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
79189197	79189197	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
AVAPRO	AVAPRO	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
IRBESARTAN	IRBESARTAN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	O	O
Number	Number	NNP	O	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/24/01	1/24/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
known	know	VBN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
Activity	Activity	NN	I-NP	O
-	-	HYPH	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
Appt	Appt	NN	B-NP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
physician	physician	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Gaines	Gaines	NNP	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Shorr	Shorr	NNP	I-NP	O
10/18/01	10/18/01	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
RECURRENT	RECURRENT	NNP	I-NP	O
VT/VFIB	VT/VFIB	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x4	x4	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
AICD	AICD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
implanted	implant	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
defibrillator	defibrillator	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
sternal	sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
sternum	sternum	NN	I-NP	O
resection	resection	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
?	?	.	O	O

amiodarone	amiodarone	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w/ischemic	w/ischemic	JJ	I-NP	O
CMP	CMP	NN	I-NP	O
and	and	CC	I-NP	O
AFib	AFib	NN	I-NP	O
dx	dx	NN	I-NP	O
5	5	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
then	then	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
last	last	JJ	B-NP	O
Tues	Tue	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
via	via	IN	B-PP	O
the	the	DT	B-NP	O
AICD	AICD	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
that	that	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
this	this	DT	B-NP	O
became	become	VBD	B-VP	O
severe	severe	JJ	B-ADJP	O
and	and	CC	O	O
assoc	assoc	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
102.4	102.4	CD	B-NP	O
yesterday	yesterday	NN	B-NP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
,	,	,	O	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
local	local	JJ	B-NP	O
ED	ED	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
in	in	IN	B-PP	O
RI	RI	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Got	Got	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
and	and	CC	O	O
Rocephin	Rocephin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
bibasilar	bibasilar	JJ	B-NP	B-cell_type
infiltrates	infiltrate	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
12.2	12.2	CD	B-NP	O
,	,	,	O	O
Bcx	Bcx	NNP	B-NP	O
's	's	POS	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
LMH	LMH	NN	B-NP	B-protein
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
request	request	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fever	fever	NN	I-NP	O
;	;	:	O	O
requires	require	VBZ	B-VP	O
FM	FM	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
;	;	:	O	O
vitals	vital	NNS	B-NP	O
stable	stable	JJ	B-ADJP	O
;	;	:	O	O
mild-mod	mild-mod	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
treat	treat	VB	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

aspiration	aspiration	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

comm	comm	NN	B-NP	O
acq	acq	NN	I-NP	O
PNA	PNA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
diurese	diurese	VB	I-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
well	well	RB	B-NP	O
perfused	perfuse	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
finally	finally	RB	B-VP	O
will	will	MD	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
underlying	underlie	VBG	I-VP	O
rhythm	rhythm	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
not	not	RB	O	O
all	all	DT	B-NP	O
beats	beat	NNS	I-NP	O
paced	pace	VBN	B-VP	O
,	,	,	O	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
if	if	IN	B-SBAR	O
back	back	RB	B-ADJP	O
in	in	IN	B-PP	O
AFib	AFib	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
CXR	CXR	NN	I-NP	O
and	and	CC	I-NP	O
F/U	F/U	NN	I-NP	O
on	on	IN	B-PP	O
cx	cx	NN	B-NP	O
's	's	POS	B-NP	O
from	from	IN	B-PP	O
SNESUHC	SNESUHC	NN	B-NP	B-protein
.	.	.	O	O

10/18	10/18	CD	B-NP	O
cx	cx	NN	I-NP	O
's	's	POS	B-NP	O
from	from	IN	B-PP	O
SMH	SMH	NN	B-NP	O
NGTD	NGTD	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
interval	interval	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
from	from	IN	B-PP	O
past	past	JJ	B-NP	O
films	film	NNS	I-NP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
small	small	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
?	?	.	O	O

aspiration	aspiration	NN	B-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
overall	overall	JJ	B-NP	O
interval	interval	NN	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

BCxs	BCx	NNS	B-NP	O
from	from	IN	B-PP	O
LWMH	LWMH	NN	B-NP	B-protein
are	be	VBP	B-VP	O
neg	neg	NN	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
ECHO	ECHO	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
po	po	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
and	and	CC	O	O
14	14	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levoflox	levoflox	NN	B-NP	O
.	.	.	O	O

sating	sate	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
seek	seek	VB	I-VP	O
immediate	immediate	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
falls	fall	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SWEERE	SWEERE	NN	B-NP	O
,	,	,	O	O
DANE	DANE	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PA12	PA12	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/24/01	1/24/01	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

